Skip to content
Wenlo
Sign in
← Markets

Tyra Biosciences, Inc.

RA CAPITAL MANAGEMENT, L.P. (Director) buys TYRA shares

4TYRAFiled Sep 17, 2026, 12:31 PM ET· Period Sep 15, 2026

About this filing

Tyra Biosciences, Inc. (TYRA) filed Form 4 (insider transaction) with the SEC on Sep 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider 1
RA CAPITAL MANAGEMENT, L.P. · Director
Insider 2
RA Capital Healthcare Fund LP · Director
Insider 3
RA Capital Nexus Fund, L.P. · Director
Insider 4
Peter Kolchinsky · Director
Insider 5
Rajeev M. Shah · Director
DateTransactionSharesPriceValueHeld afterOwnership
Sep 15, 2026P · purchasePre-Funded Warrants (Right to Buy)Footnotes F1, F2, F3+9,078,529$22.03$199,990,915.3411,616,986Indirect (See footnotes)
Footnotes
  1. F1 The Pre-Funded Warrants have no expiration date and are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Pre-Funded Warrants to the extent that it would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Persons, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 19.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.
  2. F2 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
  3. F3 Held directly by the Fund.

Remarks: Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.

More TYRA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.